Caxton Associates LP Mannkind Corp Transaction History
Caxton Associates LP
- $3.12 Billion
- Q4 2024
A detailed history of Caxton Associates LP transactions in Mannkind Corp stock. As of the latest transaction made, Caxton Associates LP holds 27,767 shares of MNKD stock, worth $138,557. This represents 0.01% of its overall portfolio holdings.
Number of Shares
27,767
Previous 80,293
65.42%
Holding current value
$138,557
Previous $504,000
64.68%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding MNKD
# of Institutions
260Shares Held
161MCall Options Held
1.97MPut Options Held
943K-
Black Rock Inc. New York, NY22.6MShares$113 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.1MShares$80.1 Million0.0% of portfolio
-
State Street Corp Boston, MA9.95MShares$49.6 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$43.7 Million0.82% of portfolio
-
Nitorum Capital, L.P. New York, NY8.75MShares$43.6 Million8.23% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.28B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...